A Study of TAE+HAIC Combined With Camrelizumab and Apatinib in the Treatment of Advanced Hepatocellular Carcinoma
Abroad (travel likely)RecruitingPHASE2
Conditions
Advanced Hepatocellular Carcinoma
Simple summaryAI-assisted
This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.
Locations
Xinhua Chen, Fuzhou, China
Study leads
Zhong Tang
Principal Investigator
Nanping First Hospital of Fujian Province
Yingchun Li
Principal Investigator
Longyan First Hospital, Affiliated to Fujian Medical University
Peishu Huang
Principal Investigator
Shanghai Sixth Hospital Fujian Hospital
Lei Yu
Principal Investigator
Sanming First Hospital